Search
for
Sort by
Research 91–120 of 1000+
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
- Challenges in the Diagnosis of Simple-Virilizing Congenital Adrenal Hyperplasia: A Case Report
- Penis Endocrinology
- Update on the dermatologic use of systemic glucocorticosteroids
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Insulin resistance and metabolic syndrome in female androgenetic alopecia
- A review of diagnosis and treatment of acne in adult female patients
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Extraskeletal actions of vitamin D
- Beyond acne: Current aspects of sebaceous gland biology and function
- Hormonal Therapy for Acne
- Oestrogen functions in skin and skin appendages
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Regulatory roles of androgens in cutaneous wound healing
- Safety of testosterone use in women
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- New approaches to the treatment of osteoporosis
- Prescribing testosterone and DHEA: The role of androgens in women
- Hormone therapy in acne
- Applications of steroid drugs entrapped in cyclodextrins
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Genetic basis of polycystic ovary syndrome
- Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China
- Androgenic disorders of women: Diagnostic and therapeutic decision making